Theralink Technologies, Inc.
OTC: THER0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael I. Ruxin
- Employees
- 16
- Headquarters
- Golden, United States
- IPO year
- 2010
- Market cap
- $615.1K
- Website
- https://theralink.com
Loading THER…
Loading profile data…Frequently asked questions about THER
What does Theralink Technologies, Inc. (THER) do?
Theralink Technologies, Inc., headquartered in Golden, Colorado, is a commercial-stage enterprise specializing in precision medicine and the generation of crucial molecular data. The company is dedicated to advancing and bringing to market innovative cancer immunotherapy products. Utilizing its proprietary platform, which focuses on phosphoprote...
Where does THER trade?
Theralink Technologies, Inc. (THER) trades on the Other OTC.
What sector is THER in?
Theralink Technologies, Inc. (THER) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Theralink Technologies, Inc.?
Michael I. Ruxin is the chief executive officer of Theralink Technologies, Inc. (THER).
Where is Theralink Technologies, Inc. headquartered?
Theralink Technologies, Inc. is headquartered in United States.
Does THER pay a dividend?
Theralink Technologies, Inc. (THER) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did THER go public?
Theralink Technologies, Inc. (THER) completed its initial public offering in 2010.